Evidence map›Paper›PMID 9889189›Full record

ArticleThe EMBO journal1999

G1 cyclins block the Ime1 pathway to make mitosis and meiosis incompatible in budding yeast.

N Colomina, E Garí, C Gallego, E Herrero, M Aldea

Abstract read
In one paragraph

Article in The EMBO journal, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. How to halve ploidy: lessons from budding yeast meiosis.Cellular and molecular life sciences : CMLS · 2012
    Review
  17. Review
  18. Article
  19. Regulation of entry into gametogenesis.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2011
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

N ColominaDepartament de Ciències Mèdiques Bàsiques, Universitat de Lleida, Rovira Roure 44, 25198 Lleida, Catalunya, Spain.
E Garí
C Gallego
E Herrero
M Aldea
Universitat de Lleida · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diploid yeast cells switch from mitosis to meiosis when starved of essential nutrients. While G1 cyclins play a key role in initiating the mitotic cell cycle, entry into meiosis depends on Ime1, a transcriptional activator regulated by both nutritional and cell-type signals. We show here that G1 cyclins downregulate IME1 transcription and prevent the accumulation of the Ime1 protein within the nucleus, which results in repression of early-meiotic gene expression. As G1-cyclin deficient cells do not require nutrient starvation to undergo meiosis, G1 cyclin would exert its role by transmitting essential nutritional signals to Ime1 function. The existence of a negative cross-talk mechanism between mitosis and meiosis may help explain why these two developmental options are incompatible in budding yeast.

Indexed as

Saccharomyces cerevisiae ProteinsTranscription FactorsCell NucleusCulture MediaCyclinsFungal ProteinsG1 PhaseGene ExpressionGenes, FungalMeiosisMitosisNuclear ProteinsSaccharomyces cerevisiaeSignal TransductionS PhaseTrans-ActivatorsCLN1 protein, S cerevisiaeCLN2 protein, S cerevisiaeCLN3 protein, S cerevisiaeCulture MediaCyclinsFungal ProteinsIME1 protein, S cerevisiaeNuclear ProteinsSaccharomyces cerevisiae ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID9889189
PMCPMC1171127
OpenAlexW2083469982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.